Kristin Krappmann

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

Carsten Denkert, Gϋnter von Minckwitz, Jan C. Brase et al. · Journal of Clinical Oncology · 2014 · 1K citations · Full text

Medicine, Immunology, Oncology +17

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Richard Buus, Ivana Šestak, Ralf Kronenwett et al. · JNCI Journal of the National Cancer Institute · 2016 · 209 citations · Full text

Medicine, Biostatistics, Oncology +17

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial

Miguel Martín, Jan C. Brase, Lourdes Calvo et al. · Breast Cancer Research · 2014 · 164 citations · Full text

Medicine, Endocrinology, Oncology +16

Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor

Sibylle Loibl, Karsten E. Weber, Jens Huober et al. · Clinical Cancer Research · 2018 · 17 citations · Full text

Medicine, Oncology, Breast Oncology +15

A genetic predisposition for bovine neonatal pancytopenia is not due to mutations in coagulation factor XI

Kristin Krappmann, Rosemarie Weikard, Sascha Gerst et al. · The Veterinary Journal · 2010 · 16 citations

Medicine, Genetics, Molecular Genetics +16